Dr. Canfield is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6410 Fannin St
Houston, TX 77030Phone+1 832-325-7280Fax+1 713-704-6260
Summary
- Dr. Steven Canfield is a urologist in Houston, TX affiliated with Memorial Hermann, Harris Health System, and M.D. Anderson Cancer Center. He received his medical degree from Thomas Jefferson University and has been in practice 21 years. He specializes in urologic oncology and is experienced in robotic surgery and focal therapy. He has more than 80 publications and over 500 citings.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2002 - 2005
- Icahn School of Medicine at Mount SinaiResidency, Urology, 1998 - 2002
- Icahn School of Medicine at Mount SinaiResidency, Surgery, 1996 - 1998
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1996
Certifications & Licensure
- TX State Medical License 2004 - 2025
- FL State Medical License 2007 - 2013
- NY State Medical License 1998 - 2008
- PA State Medical License 2006 - 2006
- American Board of Urology Urology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
Publications & Presentations
PubMed
- 478 citationsEAU guidelines on renal cell carcinoma: 2014 update.Borje Ljungberg, Karim Bensalah, Steven Canfield, Saeed Dabestani, Fabian Hofmann
European Urology. 2015-05-01 - 406 citationsGold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device studyArdeshir R. Rastinehad, Harry Anastos, Ethan Wajswol, Jared S. Winoker, John P. Sfakianos
Proceedings of the National Academy of Sciences of the United States of America. 2019-09-10 - 45 citationsRating the quality of evidence and the strength of recommendations using GRADESteven E. Canfield, Philipp Dahm
World Journal of Urology. 2011-03-09
Press Mentions
- Prostate Cancer Triplet Therapy Including Darolutamide May Be Less CardiotoxicOctober 15th, 2024
- Promaxo Announces Clinical Collaboration with Mount Sinai Health System and UTHealth HoustonFebruary 16th, 2023
- Positive Margins Post-Prostatectomy: Does Size Matter?June 29th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: